Review
Open access
Aug 2026
Effectiveness of SGLT2 inhibitors in slowing chronic kidney disease progression and reducing mortality: a meta-analysis
SGLT2 inhibitors were effective in delaying the progression of CKD and lowering mortality, however, despite having a relatively safe profile, this drug class comes with certain hazards that need to be monitored clinically.
Arjun Sharma, B. Sharma, Deepthi Sree Vamaraju et al.
· Frontiers in Pharmacology · 0 citations